top of page

Anti-NMDAR encephalitis with concomitant varicella zoster virus detection and nonteratomatous malignancy

A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis

NMDAR Encephalitis: A Possible Pathophysiological Model For Pediatric Neuropsychiatric Disorders

Predictive value of electroencephalography in anti-NMDA receptor encephalitis

Frequency, symptoms, risk factors, and outcomes of Autoimmune Encephalitis

The Movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study

Monoclonal antibodies from a patient with anti‐NMDA receptor encephalitis

Anti–NMDAR encephalitis in a patient with Crohn disease receiving adalimumab

Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection

Membrane-bound and soluble forms of an NMDA receptor extracellular domain retain epitopes targeted in auto-immune encephalitis

NMDA Receptor Autoantibodies in Autoimmune Encephalitis Cause a Subunit-Specific Nanoscale Redistribution of NMDA Receptors

Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong

Initial clinical presentation of young children with N-methyl-d-aspartate receptor encephalitis

Ion channels in EEG: isolating channel dysfunction in NMDA receptor antibody encephalitis

Early identification of anti-NMDA receptor encephalitis presenting cerebral lesions in unconventional locations on magnetic resonance imaging

Magnetic resonance imaging and positron emission tomography in anti-NMDA receptor encephalitis: A systematic review

B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets

Cerebrospinal fluid pentraxin 3 and CD40 ligand in anti-N-menthyl-d-aspartate receptor encephalitis

Anti-N-methyl-D-aspartate receptor encephalitis associated with acute Toxoplasma gondii infection

Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong

Anti-NMDA receptor encephalitis presenting as postpartum psychosis—a clinical description and review

N-methyl-D-aspartate receptor antibody production from germinal center reactions: therapeutic implications

N‐methyl‐D‐aspartate receptor antibody production from germinal center reactions: Therapeutic implications

Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis

Serum cystatin C and anti-N-methyl-D-aspartate receptor encephalitis

Non-inflammatory cerebrospinal fluid delays the diagnosis and start of immunotherapy in anti-NMDAR encephalitis

Suicidality is a common and serious feature of anti-N-methyl-D-aspartate receptor encephalitis

Arterial spin labeling perfusion imaging demonstrates cerebral hyperperfusion in anti-NMDAR

High sensitivity and specificity in proposed clinical diagnostic criteria for anti-NMDAr

Dynamic disorganization of synaptic NMDA receptors triggered by Abs from psychotic Pts

Serum complement levels in anti-N-methyl-D-aspartate receptor encephalitis

Decreased occipital lobe metabolism by FDG-PET/CT anti–NMDAr encephalitis biomarker

Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR

Cell- and Single Molecule-Based Methods to Detect Anti-NMDAr Abs in Patient w/ psychosis

Functional connectivity of large-scale brain networks in patients with anti-NMDAr encephalitis

NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody

Persistence of parenchymal and perivascular T-cells in treatment-refractory anti-N-methyl-D-aspartate receptor encephalitis

Persistence of parenchymal and perivascular T-cells in treatment-refractory NMDAr

UPENN~ Anti-NMDAR Encephalitis What is anti-NMDA Receptor Encephalitis?

Recent updates in Anti-NMDA Receptor Encephalitis Research

Comparative Outcomes in Children and Adults with anti-NMDA Receptor Encephalitis

Progressive hippocampal sclerosis after viral encephalitis: Potential role of NMDA receptor

What is the evidence to support the use of plasma exchange as first‐line therapy for NMDAr antibody encephalitis?

NMDA-receptor antibodies alter cortical microcircuit dynamics

Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis

Pathogen-mediated NMDAr autoimmunity and cellular barrier dysfunction in schizophrenia

Cognitive outcomes following anti-NMDAr encephalitis: A systematic review

anti-NMDAr encephaltis coexisting with NMO disorder or neurosyphilis

Ovarian teratoma development after anti-NMDA receptor encephalitis treatment

CSF cyto-/chemokine profile during acute HSV induced anti-NMDAr and in chronic sequelae

Herpes simplex virus-induced anti-NMDA receptor encephalitis: a systematic literature review

NMDAr: Untangling Apparant Inconsistencies for Clinical Practice

First reported cases of anti-NMDAr encephalitis in Vietnamese adolescents and adults

First reported cases of anti-NMDAr encephalitis in Vietnamese adolescents and adults

Bortezomib for Treatment of Anti-NMDA Receptor Encephalitis

Differences in treatment of anti-NMDA receptor encephalitis: results of a worldwide survey

Anti-NMDA Receptor Antibody positivity A Systematic Review of the Literature

Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis

NMDAr autoimmunity affects cognitive performance in herpes simplex encephalitis

Anti-NMDA receptor encephalitis: An emerging differential diagnosis in the psychiatric community

Potentially effective off-label: Bortezomib Treatment for Patients With NMDAr

Anti–NMDAr Encephalitis: A Potential Mimic of Neuroleptic Malignant Syndrome

Variations of movement disorders in anti-NMDAr encephalitis: A nationwide study in Taiwan

NMDAr subunit NR1 abs have pathogenic potential irrespective of epitope and immunoglobulin class

Promising results from animal model research in NMDAr w/ many potential applications

All abs against the NMDAr subunit NR1 have pathogenic potential irrespective of epitope & Ig class

New onset Headache in Patients W/ AE associated w/ NMDAr antibodies

Structural Hippocampal Damage Following Anti-N-Methyl-D-Aspartate Receptor Encephalitis

First-episode psychosis in a 15 year-old female with clinical presentation of anti-NMDAr

NMDAr encephalitis following Herpes Simplex Encephalitis Appear Different in Adults than in Children

Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of NMDA

Anti-NMDA Receptor Encephalitis in the Polar Bear (Ursus maritimus)

Anti-NMDA-receptor encephalitis: A neuropsychiatric syndrome associated with ovarian teratoma

Molecular Pathogenesis of Anti-NMDAR Encephalitis

Mayo Unravels a Mystery Disease For Minnisota Attorney

anti-NMDAr concomitant with multifocal subcortical white matter lesions on MRI

anti-NMDAr encephalitis: review of clinical presentation, diagnosis and treatment

Blood and CSF test for NMDA: Test results for CSF is 100% but Blood 87.5-94.7%.

Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis

Herpes simplex virus encephalitis is a trigger of brain autoimmunity

Increased prevalence of diverse NMDAr antibodies in patients with an initial dx of schizophrenia

Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis

Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study

Newly diagnosed brain disease may be misdiagnosed as psychological disorder

Association between the NMDA glutamate receptor GRIN2B gene and obsessive–compulsive disorder

Parents warn of mystery illness misdiagnosed in kids (NMDA)

N-methyl D-aspartate receptor encephalitis: A new addition to the spectrum of autoimmune encephalitis

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

All naturally occurring autoantibodies against the NMDA receptor (discusses BBB permeability)


Our website is not a substitute for independent professional medical advice. Nothing contained on our website is intended to be used as medical advice. No content is intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professional's advice. Although THE INTERNATIONAL AUTOIMMUNE ENCEPHALITIS SOCIETY  provides a great deal of information about AUTOIMMUNE ENCEPHALITIS, all content is provided for informational purposes only. The International Autoimmune Encephalitis Society  cannot provide medical advice.

IAE Society is a Delaware Charitable Nonprofit and a registered 501(c)(3) organization.

© 2019 International Autoimmune Encephalitis Society- All Rights Reserved.

  • Facebook Social Icon
  • Twitter Social Icon
  • YouTube Social  Icon
bottom of page